glp 1 obesity GLP-1 Medications – Community Education The GLP-1R plus strategy for
Description
But not just any food
doi:10.1002/jcph.882 185
Exenatide, a 39-amino acid peptide, is the first GLP-1R agonists approved by the US FDA in 2005 and EMA in 2007
Clinicians quoted in the article noted that care that is mostly hands-off risks inappropriate prescribing, insufficient patient support, and slower responses to warning signs
What your provider may discuss during consultation
